Treatment obese patients with type-2 – diabetes may have as insulin therapy well as other hypoglycemic drugs frequently be further weight gain challenge. In this study, the majority of participants saw improvements in blood sugar levels, improved HDL-cholesterol concentrations, and a decrease in total cholesterol and triglycerides. These results show that it is possible for the treatment of obesity surgery diabetes to lower a patient’s cardiovascular risk.
The study, the first of its kind, was conducted by researchers at the Catholic University / Policlinico Gemelli in Rome, Italy and NewYork-Presbyterian/Weill Cornell Medical Center.The NHLBI forms part of the National Institutes of Health , the U.S. Department of primary provider to of biomedicine and behavioral sciences. NIH is a component of the U.S. Department of Health and Human Services.